跳至主導覽 跳至搜尋 跳過主要內容

Refractory hypoglycemia controlled by systemic chemotherapy with advanced hepatocellular carcinoma: A case report

  • Chang Gung Memorial Hospital

研究成果: 期刊稿件 › 文章 › 同儕審查

12 引文 斯高帕斯(Scopus)

摘要

Non-islet cell tumor hypoglycemia (NICTH) is an uncommon but serious complication of malignancy. Patients with NICTH may appear unwell due to the underlying tumor, particularly when the mechanism of hypoglycemia is extensive tumor burden in the liver. Hepatocellular carcinoma (HCC) is reported to be the second most common cause of NICTH. The therapeutic strategies used in treating NICTH involve reduction of the tumor mass or tumor load, and palliative treatment of symptoms if curative attempts fail. In the present study we report the successful control of hypoglycemia using systemic chemotherapy in an advanced HCC patient who presented with refractory NICTH.

原文英語
頁(從 - 到)898-900
頁數3
期刊Oncology Letters
卷11
發行號1
DOIs
出版品狀態已出版 - 01 2016

文獻附註

Publisher Copyright:
© Spandidos Publications 2015. All right reserved.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Refractory hypoglycemia controlled by systemic chemotherapy with advanced hepatocellular carcinoma: A case report」主題。共同形成了獨特的指紋。

引用此